✦ LIBER ✦

261 Sequential vs. simultaneous administration of tamoxifen and medroxy progesterone acetate in advanced breast cancer

✍ Scribed by M. Bruno; E. Roldan; B. Diaz

Book ID: 116003713
Publisher: Elsevier Science
Year: 1983
Tongue: English
Weight: 97 KB
Volume: 19
Category: Article
ISSN: 0022-4731
DOI: 10.1016/0022-4731(83)91761-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sequential alternate administration of t

Sequential alternate administration of tamoxifen (TAM) and medroxyprogesterone acetate (MPA) in advanced breast cancer. Clinical-biological randomized study

✍ A. Paradiso; M. Brandi; E. Maiello; S. Tommasi; F. Schittulli; M. De Lena 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Tamoxifene and high dose of megestrol ac

Tamoxifene and high dose of megestrol acetate in sequential alternate therapy in advanced breast cancer

✍ Maiorino, L.; Santoro, A.; Santoro, M. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Sequential combination of tamoxifen and

Sequential combination of tamoxifen and high dose medroxyprogesterone acetate: Therapeutic and endocrine effects in postmenopausal advanced breast cancer patients

✍ Gasparini, Giampietro; Canobbio, Luciano; Galligioni, Enzo; Fassio, Tiziana; Bre 📂 Article 📅 1987 🏛 Elsevier Science ⚖ 876 KB

Intermittent/alternated therapy with tam

Intermittent/alternated therapy with tamoxifen and medroxy-progesterone acetate prolongs time to resistance to tamoxifen without benefit for (progression free) survival in patients with advanced breast cancer. Results of an EORTC phase III study (trial 10863)

✍ L Beex; C Rose; H Mouridsen; J Jassem; M Nooy; J Estape; R Paridaens; M.J Piccar 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Clinical trial of Δ1-testololactone (NSC

Clinical trial of Δ1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer: A report of the cooperative breast cancer group

✍ Ira S. Goldenberg 📂 Article 📅 1969 🏛 John Wiley and Sons 🌐 English ⚖ 329 KB 👁 1 views

A'-TESTOLOLACTONE (NSC 23759), MEDROXY PROGESTERONE ACETATE (NSC 26386) AND OXYLONE ACETATE (NSC 47438) I N ADVANCED FEMALE MAMMARY CANCER A Reil,ort of the Cooperative Byeast Cancer G ~u ~I REPORT PREPARED HY IRA S. GOI-DEKHERG, MD Three hundred and nineteen women with advanced and metastatic carci

The effect of Tamoxifen (T) on Progester

The effect of Tamoxifen (T) on Progesterone Receptor (PR): Relationship of a rise in PR to response and the effect of alternating T and Medroxyprogesterone Acetate (MPA) in patients with advanced breast cancer

✍ Barnes, Diana M.; Howell, A.; Harland, R.N.L.; Baildan, A.D.; Swindell, R.; Sell 📂 Article 📅 1986 🏛 Elsevier Science ⚖ 149 KB